- Valeant is back in the news $VRX
- Regeneron reloads pipeline with Intellia deal $REGN $NTLA
- FDA, Advisory Committee take dim view of Clovis lung cancer drug $CLVS
- Internet mogul Sean Parker enters immuno-oncology fray
- PTC gets reimbursement nod from UK price watch dog $PTCT
- As seen on the stream (the best of everything else, including $CHMA $DEPO $HZNP $MDVN $RLYP $SNTA $XBI $IBB
Continue to the Biotech Tweets of the Week (April 11-15, 2016)